# FDA Warns Against Two Popular Glucose Monitors Over Safety Risks

The FDA has issued a warning about two glucose monitoring devices, flagging them as potential safety hazards for users who depend on accurate blood sugar readings.

The agency identified specific models that pose risks to users, though the exact nature of the hazard requires immediate attention from anyone currently using these devices. Users are advised to discontinue use and dispose of affected monitors promptly.

Glucose monitors are essential tools for people with diabetes and those monitoring metabolic health. Millions of Americans rely on these devices to track blood sugar levels and make critical decisions about insulin dosing, medication timing, and dietary choices. When a glucose monitor malfunctions or provides inaccurate readings, the consequences extend beyond inconvenience, potentially leading to dangerous blood sugar fluctuations and serious health complications.

The FDA's warning system exists specifically to catch these kinds of issues after devices reach consumers. The agency investigates reports of device failures, inaccurate readings, or manufacturing defects that slip past initial quality controls. When patterns emerge, the FDA alerts healthcare providers and the public.

For anyone currently using a glucose monitor, checking the FDA's official website for device recalls and warnings should become routine. The agency maintains updated lists of affected models, serial numbers, and batch codes. Users can cross-reference their devices against these lists to determine if their monitor falls within the warning parameters.

People who have discarded affected monitors should consult with their healthcare provider about appropriate alternatives. The market includes numerous reliable glucose monitoring options, and a doctor can recommend devices suited to individual needs and lifestyle. Continuity of monitoring remains essential during any transition period between devices.

This warning underscores the importance of purchasing medical devices from reputable retailers and maintaining awareness of FDA announcements. Users should register their glucose monitors with manufacturers when possible, which can help ensure they receive direct notification if safety issues emerge later. Regular device